Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Growth Metrics

HealthLynked (HLYK) Divestments (2023)

HealthLynked (HLYK) has disclosed Divestments for 1 consecutive years, with $1.2 million as the latest value for Q4 2023.

Quarterly Divestments changed N/A to $1.2 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Dec 2023, changed N/A year-over-year, with the annual reading at $425000.0 for FY2024, 87.88% down from the prior year.
Divestments for Q4 2023 was $1.2 million at HealthLynked, up from $360000.0 in the prior quarter.
The five-year high for Divestments was $1.2 million in Q4 2023, with the low at $360000.0 in Q3 2023.